80 results
Page 3 of 4
8-K
EX-1.1
swtw2o
6 May 21
Entry into a Material Definitive Agreement
5:10pm
424B5
7ov3sum8wsjq40
6 May 21
Prospectus supplement for primary offering
5:01pm
S-3ASR
EX-4.2
9sf0z6764mq 8dnl2e
6 May 21
Automatic shelf registration
4:33pm
S-3ASR
zmenlvy5ss18sa
6 May 21
Automatic shelf registration
4:33pm
DEF 14A
nye8ons0l0gylswg nv
26 Apr 21
Definitive proxy
6:05am
S-8
6okvza
23 Mar 21
Registration of securities for employees
4:50pm
10-K
5prapliq4jrzw7726m
23 Mar 21
Annual report
4:21pm
8-K
EX-99.2
34kjkqnf3qd
11 Jan 21
ORIC Pharmaceuticals Provides Corporate Update and Highlights Key 2021 Milestones
6:36am
424B4
jhj1og1
13 Nov 20
Prospectus supplement with pricing info
5:21pm
S-1MEF
7q29j tzhvv4
13 Nov 20
Registration of additional securities for an S-1
6:05am
DRS
qlwgxmuqjxcxazj8
20 Jul 20
Draft registration statement
12:00am
10-Q
oheejj95tk672lzcc8b
20 May 20
Quarterly report
4:31pm
8-K
EX-3.2
v1cpl8f
28 Apr 20
ORIC Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
5:22pm
S-8
oei5rowlty54mftsibl4
24 Apr 20
Registration of securities for employees
5:09pm
424B4
1ywd6j h8jp2
24 Apr 20
Prospectus supplement with pricing info
5:04pm